We measured advanced glycosylation end products in the mesenteric artery of 37 patients (ages 29-82 years), 34 of whom were nondiabetic. Samples of arterial tissue were obtained during bowel resectioning. Advanced glycosylation end products were measured as collagen-linked fluorescence (excitation wavelength 370 nm, emission wavelength 440 nm) after collagenase digestion of tissue samples. Mean fluorescence of the arterial samples was 15 U/mg (range 5.3-27). Collagen fluorescence correlated with patients' age (r = 0.57; P <0.001). No difference in the collagen-linked fluorescence was observed between men and women (P = 0.63), hypertensive and normotensive patients (P = 0.44), smokers and nonsmokers (P = -0.52), and patients with and without symptomatic coronary heart disease (P = 0.7). This study demonstrates, for the first time, the relationship between collagen-linked fluorescence and patients' age in human arterial tissue ex vivo. 
AGE formation on colla-
gen has been demonstrated in animals (6) and humans (7) . Clinical studies of AGE have measured CLF of skin biopsy specimens.
However, because in vitro experiments suggest that the accumulation of AGE may play a role in the pathogenesis of vascular complications of diabetes and in atherogenesis (4,5), the direct measurement of AGE in arterial tissue is important.
Here we measure the fluorescence of collagen in human arterial tissue obtained ex vivo and study the relationship between fluorescence of arterial collagen and patients' age.
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Received October 11, 1991; accepted February 14, 1992. Excitation at 370 nm 0.57, P <0.001) (Figure 2 in patients with malignancy, and in patients with and without symptomatic ischemic heart disease (P = 0.7). CLF was not affected by sex (P = 0.63) or cigarette smoking (P = 0.52). We studied small mesenteric arteries because they are easily obtained untraumatized during bowel surgery and may play an important role in regulating the cardiovascular system, particularly systemic blood pressure (27) . Although the arteries studied were taken from patients with underlying bowel disease, histological examination showed no involvement by the primary pathology. Malignancy is unlikely to affect the structure of collagen crosslinks, and we were unable to detect any difference in CLF between patients with and without neoplasia.
MaterIals and Methods

DIscussIon
2-(2-Furoyl)-4-(5)-(2-fiiranyl)-1-H-imidazole was the
The arterial CLF in our patients increased slowly up to age 60 years and increased rapidly thereafter. This is similar to the exponential pattern of the pentosidine accumulation in the human skin from individuals between ages 10 and 100 years (13, 28). A similar pattern of CLF increase was observed in aging nondiabetic and streptozotocin-diabetic rats (29). The age-related increase in CLF in human skin and dura mater was previously reported (30, 31 The importance of our finding is the direct demonstration of age-related increases in AGE concentrations in human arterial tissue ex vivo. The age-related increase in the arterial-wall AGE content supports the hypotheses relating AGE accumulation to vascular pathology. The mesenteric artery used is a good model for studies of advanced glycosylation in human arterial tissue. 
